According to a study conducted by scientists at Weill Cornell Medicine, the vertebral bones that make up the spine originate from a special kind of stem cell that secretes a protein that encourages tumour metastasis.

The finding opens up a new area of study into spinal illnesses, sheds light on why solid tumours frequently metastasise to the spine and may assist in the development of new cancer and orthopaedic therapies.

In the study, which was released in Nature, the researchers found that spinal bone is produced by a distinct type of stem cell from other bone-producing stem cells.

Using "organoids" that resembled bones that were created from vertebral stem cells, scientists demonstrated that a protein called MFGE8 released by these stem cells is substantially responsible for the known predisposition of tumours to travel to the spine more so than to long bones like leg bones.

“We suspect that many bone diseases preferentially involving the spine are attributable to the distinct properties of vertebral bone stem cells,” said study senior author Dr. Matthew Greenblatt, an associate professor of pathology and laboratory medicine and a member of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and a pathologist at NewYork-Presbyterian/Weill Cornell Medical Center.

In recent years, Dr. Greenblatt and other scientists have found that different types of bone are derived from different types of bone stem cells.

Since vertebrae, in comparison with other bones such as arm and leg bones, develop along a different pathway early in life, and also appear to have had a distinct evolutionary trajectory, Dr. Greenblatt and his team hypothesised that a distinct vertebral stem cell probably exists.

The researchers started out by isolating what is broadly known as skeletal stem cells, which give rise to all bone and cartilage, from different bones in lab experimental models based on known surface protein markers of such cells.

They then analysed gene activity in these cells to see if they could find a distinct pattern for the ones associated with vertebral bone.

This effort yielded two key findings. The first was a new and more accurate surface-marker-based definition of skeletal stem cells as a whole. This new definition excluded a set of cells that were not stem cells that had been included in the old stem cell definition, thus clouding some prior research in this area.

The second finding was that skeletal stem cells from different bones do indeed vary systematically in their gene activity. From this analysis, the team identified a distinct set of markers for vertebral stem cells and confirmed these cells’ functional roles in forming spinal bone in further experiments in experimental models and in lab-dish cell culture systems.

The researchers next investigated the phenomenon of the spine’s relative attraction for tumour metastases including breast, prostate and lung tumour metastases compared to other types of bone.

The traditional theory, dating to the 1940s, is that this “spinal tropism” relates to patterns of blood flow that preferentially convey metastases to the spine versus long bones.

But when the researchers reproduced the spinal tropism phenomenon in experimental models, they found evidence that blood flow isn’t the explanation indeed, they found a clue pointing to vertebral stem cells as the possible culprits.

“We observed that the site of initial seeding of metastatic tumour cells was predominantly in an area of marrow where vertebral stem cells and their progeny cells would be located,” said study first author Dr. Jun Sun, a postdoctoral researcher in the Greenblatt laboratory.

Subsequently, the team found that removing vertebral stem cells eliminated the difference in metastasis rates between spine bones and long bones. Ultimately, they determined that MFGE8, a protein secreted in higher amounts by vertebral compared to long bone stem cells, is a major contributor to spinal tropism.

To confirm the relevance of the findings in humans, the team collaborated with investigators at the Hospital for Special Surgery to identify the human counterparts of the experimental model's vertebral stem cells and characterise their properties.

The researchers are now exploring methods for blocking MFGE8 to reduce the risk of spinal metastasis in cancer patients. More generally, said Dr. Greenblatt, they are studying how the distinctive properties of vertebral stem cells contribute to spinal disorders.

“There’s a subdiscipline in orthopaedics called spinal orthopaedics, and we think that most of the conditions in that clinical category have to do with this stem cell we’ve just identified,” Dr. Greenblatt said.